Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

348 ARTÍCULOS , VIENDO DEL 151 AL 165

PSEN1 L226F mutation in a patient with early-onset Alzheimer's disease in Korea

Bagyinszky E, Park SA, Kim HJ, Choi SH, An SS, Kim SY.

Clin Interv Aging. 2016 Oct 12;11:1433-1440. doi: 10.2147/CIA.S111821. eCollection 2016.

Structural MR Imaging in the Diagnosis of Alzheimer's Disease and Other Neurodegenerative Dementia: Current Imaging Approach and Future Perspectives

Park M, Moon WJ.

Korean J Radiol. 2016 Nov-Dec;17(6):827-845. doi: 10.3348/kjr.2016.17.6.827. Epub 2016 Oct 31.

Effect of concomitant use of memantine on mortality and efficacy outcomes of galantamine-treated patients with Alzheimer's disease: post-hoc analysis of a randomized placebo-controlled study

Hager K, Baseman AS, Nye JS, Brashear HR, Han J, Sano M, Davis B, Richards HM.

Alzheimers Res Ther. 2016 Nov 15;8(1):47. doi: 10.1186/s13195-016-0214-x.

Flashbulb memories of Paris attacks: Recall of these events and subjective reliving of these memories in a case with Alzheimer disease

El Haj M, Gandolphe MC, Wawrziczny E, Antoine P.

Medicine (Baltimore). 2016 Nov;95(46):e5448. doi: 10.1097/MD.0000000000005448.

Predictors of care home and hospital admissions and their costs for older people with Alzheimer's disease: findings from a large London case register

Knapp M, Chua KC, Broadbent M, Chang CK, Fernandez JL, Milea D, Romeo R, Lovestone S, Spencer M, Thompson G, Stewart R, Hayes RD.

BMJ Open. 2016 Nov 18;6(11):e013591. doi: 10.1136/bmjopen-2016-013591.

Molecular imaging in the diagnosis of Alzheimer's disease and related disorders

Koric L, Guedj E, Habert MO, Semah F, Branger P, Payoux P, Le Jeune F; CMMR study group.

Rev Neurol (Paris). 2016 Dec;172(12):725-734. doi: 10.1016/j.neurol.2016.10.009. Epub 2016 Nov 17.

Resource utilisation, costs and clinical outcomes in non-institutionalised patients with Alzheimer's disease: 18-month UK results from the GERAS observational study

Lenox-Smith A, Reed C, Lebrec J, Belger M, Jones RW.

BMC Geriatr. 2016 Nov 25;16(1):195. doi: 10.1186/s12877-016-0371-6.

Alzheimer's disease: expedition into the unknown

The Lancet.

Lancet. 2016 Dec 3;388(10061):2713. doi: 10.1016/S0140-6736(16)32457-6. Epub 2016 Dec 2.

Usefulness of 3-dimensional stereotactic surface projection FDG PET images for the diagnosis of dementia

Kim J, Cho SG, Song M, Kang SR, Kwon SY, Choi KH, Choi SM, Kim BC, Song HC.

Medicine (Baltimore). 2016 Dec;95(49):e5622. doi: 10.1097/MD.0000000000005622.

Special Issue: "Molecules against Alzheimer"

Decker M, Muñoz-Torrero D.

Molecules. 2016 Dec 16;21(12):1736. doi: 10.3390/molecules21121736.

A Case of Multiple System Atrophy with Preexisting Alzheimer's Disease and Predating The Hot Cross Bun Sign

Lin CW, Tseng CY, Lo CP, Tu MC.

Acta Neurol Taiwan. 2016 Dec 15;25(4):152-159.

Structured Sparse Kernel Learning for Imaging Genetics Based Alzheimer's Disease Diagnosis

Peng J, An L, Zhu X, Jin Y, Shen D.

Med Image Comput Comput Assist Interv. 2016 Oct;9901:70-78. doi: 10.1007/978-3-319-46723-8_9. Epub 2016 Oct 2.

From Subjective Cognitive Complaints to Dementia: Who is at Risk?: A Systematic Review

Mendonça MD, Alves L, Bugalho P.

Am J Alzheimers Dis Other Demen. 2016 Mar;31(2):105-14. doi: 10.1177/1533317515592331.

Cognitive Impairment, Neuroimaging, and Alzheimer Neuropathology in Mouse Models of Down Syndrome

Hamlett ED, Boger HA, Ledreux A, Kelley CM, Mufson EJ, Falangola MF, Guilfoyle DN, Nixon RA, Patterson D, Duval N, Granholm AC.

Curr Alzheimer Res. 2016;13(1):35-52. doi: 10.2174/1567205012666150921095505.

[Cognitive rehabilitation in early stage Alzheimer's disease]

Kasper E, Thöne-Otto A, Bürger K, Schröder SG, Hoffmann W, Schneider W, Teipel S.

Nervenarzt. 2016 Jul;87(7):708-18. doi: 10.1007/s00115-015-4426-2.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias